<DOC>
	<DOCNO>NCT01985321</DOCNO>
	<brief_summary>The purpose study determine Merlin , mixture ethanol glycolic acid , safe effective treatment cold sore . Subjects meet requirement participate study put randomly , equally , one two group : 1 ) group receive Merlin treat cold sore ; 2 ) group receive placebo ethanol treat cold sore . Neither subject site know treatment get . Once subject assign treatment group , give kit contain bottle treatment special swab apply liquid . The subject tell take kit home wait think start get cold sore . Once subject begin feel something see something think start cold sore , immediately call clinic . Once clinic confirms subject fact start get cold sore , subject tell open kit begin treatment . From start treatment , twelve ( 12 ) treatment , either Merlin placebo , apply six ( 6 ) hour apart , 3 per day , next 96 hour ( 4 day ) . Each treatment Merlin placebo make three ( 3 ) application give twenty ( 20 ) minute apart , total thirty-six ( 36 ) application . FOr application , subject use special swab put Merlin placebo solution cold sore . Subjects need report daily clinic minimum 3 consecutive day , either cold sore completely heal 14 day start treatment , whichever come first . At clinic visit cold sore observed determine stage heal . The subject also ask feeling . Subjects also tell record diary time application Merlin placebo . They also ask record much pain , , related cold sore , feeling .</brief_summary>
	<brief_title>Safety Efficacy Merlin ( Ethanol Glycolic Acid Mixture ) Treatment Cold Sores</brief_title>
	<detailed_description />
	<mesh_term>Herpes Labialis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Glycolic acid</mesh_term>
	<criteria>Male female subject 1875 year age Female subject must use medically acceptable form birth control study . Acceptable birth control measure include , limited : abstinence , oral contraceptive pill patch , injectable contraception , barrier contraceptive ( condom , diaphragm spermicide ) , IUD , vaginal contraceptive ring , surgical ( hysterectomy , tubal ligation ) , vasectomized partner , natural postmenopausal inability conceive . Menopause define protocol start one year time last menstrual period . Subject must history recurrent herpes labialis report least 3 separate recurrence ( i.e . multiple herpetic lesion one outbreak count one episode ) precede 12 month . Subject must history experience prodromal symptom cold sore ( e.g . itching , tingle , burn ) least half previous cold sore episode . Subject must history least half cold sore episode produce classical lesion ( i.e. , episode progress macule , papule , vesicle , crust , heal ) . Subject must provide voluntary write informed consent participate study . Subject able appear clinic visit within 24 hour time treat cold sore able return clinic full 14 day duration study necessary . Subjects evidence active malignancy immunodeficiency disease within last 30 day . Subjects complete therapy consider unlikely relapse surgery evidence disease , eligible study . Subject require chronic use immunomodifying drug ( e.g . systemic steroid ) topical steroid near face ; use inhale steroid exclude subject study . If subject unlikely get Treatment Phase protocol without require use immunomodifying drug chronic condition subject exclude . Subject require chronic use antiviral medication . In female childbearing potential , positive urine pregnancy test time screen . Nursing mother . Subject abnormal skin condition ( e.g . acne , eczema , rosacea , psoriasis , albinism , chronic vesiculobullous disorder ) occur area ordinarily affect cold sore significant facial hair area cold sore might affect normal course cold sore might impair accurate evaluation cold sore lesion . Subject vaccine herpes simplex virus type 1 ( typically oral herpes ) 2 ( typically genital herpes ) . Subject currently enrol another clinical trial involve use drug and/or device . Subject require chronic use analgesic nonsteroidal antiinflammatory agent ( NSAIDs ) except low dos aspirin ( less 325 mg/day ) use cardiovascular purpose . If subject unlikely get Treatment Phase protocol without require use analgesia chronic condition , e.g . back pain , recurrent daily headache , subject exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>herpes labialis</keyword>
	<keyword>cold sore</keyword>
</DOC>